Vanguard Fiduciary Trust
PLRX icon

Vanguard Fiduciary Trust’s Pliant Therapeutics PLRX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Buy
341,751
+2,211
+0.7% +$2.69K ﹤0.01% 3355
2026
Q1 		$428K Buy
+339,540
New +$429K ﹤0.01% 3260

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Vanguard Fiduciary Trust's PLRX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Pliant Therapeutics (PLRX) stake by 0.65% in Q2 2026, buying an estimated $2.69K and bringing the position to 341,751 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3355.

Vanguard Fiduciary Trust first reported a position in PLRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $428K in Q1 2026. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Vanguard Fiduciary Trust held 341,751 shares of Pliant Therapeutics worth $390K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 2,211 Pliant Therapeutics shares in Q2 2026, an estimated $2.69K.
  • Pliant Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3355 holding.
  • Vanguard Fiduciary Trust first reported a position in Pliant Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Pliant Therapeutics position peaked at $428K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.